GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Althea Group Holdings Ltd (OTCPK:AHGHF) » Definitions » Common Stock

Althea Group Holdings (Althea Group Holdings) Common Stock : $57.67 Mil (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Althea Group Holdings Common Stock?

Althea Group Holdings's quarterly common stock declined from Dec. 2022 ($57.35 Mil) to Jun. 2023 ($57.28 Mil) but then increased from Jun. 2023 ($57.28 Mil) to Dec. 2023 ($57.67 Mil).

Althea Group Holdings's annual common stock increased from Jun. 2021 ($52.02 Mil) to Jun. 2022 ($57.66 Mil) but then declined from Jun. 2022 ($57.66 Mil) to Jun. 2023 ($57.28 Mil).


Althea Group Holdings Common Stock Historical Data

The historical data trend for Althea Group Holdings's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Althea Group Holdings Common Stock Chart

Althea Group Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23
Common Stock
17.87 37.55 52.02 57.66 57.28

Althea Group Holdings Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 58.35 57.66 57.35 57.28 57.67

Althea Group Holdings Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Althea Group Holdings (Althea Group Holdings) Business Description

Traded in Other Exchanges
Address
360 Elizabeth Street, Suite 2, Level 50, Melbourne, VIC, AUS, 3000
Althea Group Holdings Ltd is engaged in the manufacturing, sales, and distribution of cannabis-based medicines and recreational cannabis products. It operates in three reportable segments Pharmaceutical Cannabis, Recreational Cannabis, and Corporate in which it generates the majority of its revenue from Pharmaceutical Cannabis. It operates into four geographic segments: Australia, the United Kingdom, Canada, and others. The company earns key revenue from Australia and through the sale of medicinal cannabis products.

Althea Group Holdings (Althea Group Holdings) Headlines